Blue-black discoloration of the nails associated with gefitinib

Acta Clinica Belgica

Volumn 66, Issue 1, 2011, Pages 72-

  Huan, T C ^a   Ho, Ching Liang ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GEFITINIB;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HUMAN; LUNG CANCER; NAIL COLOR DEFECT;

ANTINEOPLASTIC AGENTS; COLOR; FEMALE; HUMANS; MIDDLE AGED; NAILS; QUINAZOLINES;

EID: 79952585205     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.2143/ACB.66.1.2062522     Document Type: Article

References (3)

1. Heidary H, Naik H, Burgin S. Chemotherapeutic agents and the skin: An update. J Am Acad Dermatol 2008; 59: 545-570. (Pubitemid 351375051)
2. Agero AL, Dusza SW, Benvenuto-Andrade C, et al. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 2006; 55: 657-670. (Pubitemid 44436627)
3. Cohen PR. The lunula. J Am Acad Dermatol 1996; 34: 943-953. (Pubitemid 26000144)